cyclohexyl-(3-diethylamino-propyl)-carbodiimide | 109341-26-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: cyclohexyl-(3-diethylamino-propyl)-carbodiimide
• 英文别名: Cyclohexyl-(3-diaethylamino-propyl)-carbodiimid
• CAS: 109341-26-6
• 化学式: C₁₄H₂₇N₃
• 分子量: 237.388
• InChiKey: NBAOCBDTKIJPBL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  28
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  cyclohexyl-(3-diethylamino-propyl)-carbodiimide 、 碘甲烷 以 乙醚 为溶剂， 以82%的产率得到(3-Cyclohexyliminomethyleneamino-propyl)-diethyl-methyl-ammonium; iodide
  参考文献：
  名称：

  Preparation of Carbodiimides from Phosphoramidates

  摘要：

  在两相体系中，Ï-二烷基氨基烷基磷酰胺酸盐通过与异氰酸酯反应，以良好的收率转化为Ï-二烷基氨基烷基（烷基）碳二亚胺。

  DOI：

  10.1055/s-1988-27590
• 作为产物：
  描述：

  3-(二乙基氨基)丙基异硫氰酸酯 在 二氯甲烷 、 alkaline aqueous NaClO 作用下， 生成 cyclohexyl-(3-diethylamino-propyl)-carbodiimide
  参考文献：
  名称：

  Nucleoside Polyphosphates. VI.¹ An Improved and General Method for the Synthesis of Ribo- and Deoxyribonucleoside 5'-Triphosphates

  摘要：

  DOI：

  10.1021/ja01538a033

文献信息

• Peptide skeletal muscle relaxants
  申请人：BOC Health Care, Inc.

  公开号：EP0498941A2

  公开（公告）日：1992-08-19

  A method of achieving muscle relaxation comprising administering a polypeptide represented by the formula: wherein m is 0 or 1, n is 3-5, x is 0 or 2; R is lower alkyl, R₁ and R₂ are independently hydrogen, lower alkyl, allyl, propargyl, aryl lower alkyl, cyclo-lower alkyl lower alkyl and -COOR₃ or R plus one or both of R₁ and R₂ and the attached nitrogen form a 5- to 7-member heterocyclic ring, at least one AA is a basic amino acid, at least one AA is a lipophilic amino acid, Y is -NH₂ or -OR₄, R₃ is t-butyl, benzyl or fluorenylmethyl, and R₄ is lower alkyl, aryl lower alkyl and N-(lower alkyl)piperidyl lower alkyl, Z is a pharmaceutically acceptable anion and, wherein m and x are 0, pharmaceutically acceptable acid addition salts thereof. Diquaternary compounds within the above formula are novel.

  一种实现肌肉放松的方法，包括施用由式表示的多肽： 其中 m 为 0 或 1，n 为 3-5，x 为 0 或 2；R是低级烷基，R₁和R₂独立地是氢、低级烷基、烯丙基、丙炔基、芳基低级烷基、环低级烷基低级烷基和-COOR₃或 R加上R₁和R₂中的一个或两个以及所连接的氮形成5-7元杂环，至少一个AA是碱性氨基酸、至少一种 AA 是亲脂性氨基酸，Y 是-NH₂ 或-OR₄，R₃ 是叔丁基、苄基或芴甲基，R₄ 是低级烷基、芳基低级烷基和 N-(低级烷基)哌啶基低级烷基，Z 是药学上可接受的阴离子，其中 m 和 x 为 0，是药学上可接受的酸加成盐。上式中的二季化合物是新颖的。
• Peptide amides and amide dimers
  申请人：BOC Health Care, Inc.

  公开号：EP0498940A2

  公开（公告）日：1992-08-19

  Peptide amide and amide dimer muscle relaxants represented by the formulae: wherein: R is lower alkyl; R₁ and R₂ independently selected from the group consisting of hydrogen, lower alkyl, allyl, propargyl, aryl lower alkyl and cyclo-lower alkyl lower alkyl, or R plus one or both of R₁ and R₂, together with the nitrogen to which they are attached, form a heterocyclic ring having 5 to 7 member atoms; AA are independently selected from certain amino acids moieties; n is 2 to 4; x is independently 0 or 1; y is independently 1 or 2; z is 2 to 12; and and An⁻ is a pharmaceutically acceptable anion.

  肽酰胺和酰胺二聚体肌肉松弛剂的配方： 其中R是低级烷基；R₁和R₂独立地选自氢、低级烷基、烯丙基、丙炔基、芳基低级烷基和环低级烷基低级烷基组成的组，或R加上R₁和R₂中的一个或两个，连同它们所连接的氮，形成一个具有5至7个成员原子的杂环；AA 独立地选自某些氨基酸分子；n 为 2 至 4；x 独立地为 0 或 1；y 独立地为 1 或 2；z 为 2 至 12；An- 为药学上可接受的阴离子。
• Motilin-like polypeptides that inhibit gastrointestinal motor activity
  申请人：Ohmeda Pharmaceutical Products Division Inc.

  公开号：EP0647656A1

  公开（公告）日：1995-04-12

  This invention pertains to polypeptides having gastrointestinal motor inhibitory activity represented by the formula: including optically active isomeric forms and the pharmaceutically acceptable acid addition salts thereof wherein A is the L-stereoisomer of a lipophilic aliphatic or alicyclic amino acid; B is selected from the group consisting of L and D aromatic, heteroaromatic, lipophilic aliphatic, and alicyclic amino acids; D is the L-stereoisomer of a lipophilic aliphatic or alicyclic amino acid; E is the L-stereoisomer of an aromatic, aliphatic, or alicyclic amino acid; F is the L-stereoisomer of an aromatic or heteroaromatic amino acid; G is glycine or D-alanine; H is L-glutamic acid or L-glutamine; I is L-glutamine, L-glutamic acid, or L-alanine; J is a direct bond between I and group -NH- or is selected from the group consisting of Z, Z-Leu, Z-Leu-Gln, Z-Leu-Gln-Glu, Z-Leu-Gln-Glu-Lys, Z-Leu-Gln-Glu-Lys-Glu, Z-Leu-Gln-Glu-Lys-Glu-Arg, Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn, Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys, and Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly, wherein Z is selected from the group consisting of arginine, D-arginine, D-homoarginine, D-lysine, D-ornithine, D-2,4-diaminobutyric acid, D-glutamine, D-asparagine, and D-atanine; R₁ and R₂ are independently hydrogen or lower-alkyl; R₃ is selected from the group consisting of lower-alkyl, cycloalkyl, substituted and unsubstituted aryl, and heteroaryl, wherein the aryl group may be substituted with one or more substituents selected from the group consisting of halogen, hydroxy, and lower-alkoxy; R₄ is selected from the group consisting of -CH₂CONH₂, aminoalkyl groups containing from 1 to 3 carbon atoms, and guanidinoalkyl groups containing 2 or 3 carbon atoms; R₅ is -COOH or -CONH₂; and the symbol * represents an asymmetric carbon atom which may be in the D or L configuration, and each lower-alkyl group contains from 1 to 4 carbon atoms, with the proviso that R₄ is -CH₂CONH₂ only when J is Z-Leu or Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly.

  本发明涉及具有胃肠道运动抑制活性的多肽，由式表示： 包括光学活性异构体形式及其药学上可接受的酸加成盐 其中 A 是亲脂性脂肪族或脂环族氨基酸的 L-立体异构体；B 选自 L 和 D 芳族、杂芳族、亲脂性脂肪族和脂环族氨基酸组成的组；D 是亲脂脂肪族或脂环族氨基酸的 L-立体异构体； E 是芳香族、脂肪族或脂环族氨基酸的 L-立体异构体； F 是芳香族或杂芳香族氨基酸的 L-立体异构体； G 是甘氨酸或 D-丙氨酸；H 是 L-谷氨酸或 L-谷氨酰胺；I 是 L-谷氨酰胺、L-谷氨酸或 L-丙氨酸；和 Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly，其中 Z 选自由精氨酸、D-精氨酸、D-高精氨酸、D-赖氨酸、D-鸟氨酸、D-2,4-二氨基丁酸、D-谷氨酰胺、D-天冬酰胺和 D-天冬氨酸组成的组；R₁ 和 R₂ 独立地为氢或低级烷基；R₃ 选自由低级烷基、环烷基、取代和未取代的芳基和杂芳基组成的组，其中芳基可被一个或多个选自由卤素、羟基和低级烷氧基组成的组的取代基取代；R₄ 选自由 -CH₂CONH₂、含 1 至 3 个碳原子的氨基烷基和含 2 或 3 个碳原子的胍基所组成的组； R₅ 是 -COOH 或 -CONH₂；符号 * 代表不对称碳原子，可以是 D 或 L 构型，每个低级烷基含有 1 至 4 个碳原子，但只有当 J 为 Z-Leu 或 Z-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly 时，R₄ 才是 -CH₂CONH₂。
• HASHIMOTO, NAOTO;KISHI, TOYOKAZU
  作者：HASHIMOTO, NAOTO、KISHI, TOYOKAZU

  DOI：——

  日期：——
• Motilin-like polypeptides with gastrointestinal motor stimulating activity
  申请人：Baxter International Inc.

  公开号：EP0646601B1

  公开（公告）日：2000-07-12